Literature DB >> 7259964

Non-Hodgkin's lymphoma, chronic lymphatic leukaemia and the lung.

P F Jenkins, M J Ward, P Davies, J Fletcher.   

Abstract

In a retrospective study of 81 patients with non-Hodgkins's lymphoma and 35 patients with chronic lymphatic leukaemia, pulmonary involvement was found in 25% of cases and pleural effusion in 19%. Twenty-four patients (20%) had intrathoracic lymphadenopathy and 12 of these had associated pleural or lung involvement. Infiltration occurred almost exclusively in diffuse lymphocytic lymphoma and chronic lymphatic leukaemia, whereas round lesions were seen only in undifferentiated lymphomas. Pleural effusion complicated most histological types of non-Hodgkin's lymphoma but was uncommon in chronic lymphatic leukaemia. Pleural biopsy was successful in diagnosing lymphoma in nine of ten patients with an effusion in whom it was performed. Both pulmonary and pleural involvement responded poorly to treatment and had an adverse effect on prognosis. In contrast, intrathoracic lymphadenopathy responded well to radiotherapy and/or chemotherapy and did not affect prognosis adversely when it occurred in the absence of other intrathoracic manifestations of lymphoma.

Entities:  

Mesh:

Year:  1981        PMID: 7259964     DOI: 10.1016/s0007-0971(81)80004-6

Source DB:  PubMed          Journal:  Br J Dis Chest        ISSN: 0007-0971


  3 in total

1.  Successful pleurodesis for refractory chylothorax due to chronic lymphocytic leukemia.

Authors:  George E Philippakis; Marios P Moustardas
Journal:  Int J Surg Case Rep       Date:  2012-01-28

2.  Sputum cytology in the diagnosis of pulmonary non-Hodgkin's lymphoma.

Authors:  A Manoharan; J Ford; J Hill; D Painter; D Miller
Journal:  Thorax       Date:  1984-05       Impact factor: 9.139

3.  Pleural effusion aetiology, presentation, treatment and outcome in haematological diseases: a review.

Authors:  Alberto Fantin; Nadia Castaldo; Paolo Vailati; Giuseppe Morana; Daniele Orso; Luigi Vetrugno; Vincenzo Patruno
Journal:  Acta Biomed       Date:  2021-11-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.